/24-7PressRelease/ - IRVINE, CA, May 26, 2007 - Sequence XO, a nutritional supplement company exclusive to spas, announced the availability of their latest product, Calm. Finally, true internal relaxation is achieved with this powerful combination of extracts, herbs, vitamins, and minerals developed specifically to meet the needs of spa goers. The primary ingredient in this effective product is Lactium . Lactium is a well researched milk protein hydrolasate developed and tested in France. This new ingredient, plus the combination of a B-Complex blend, Ashwangandha, and other ingredients including GABA and Rhodiola rosea give Calm its effective and potent relaxation properties. The relaxation also includes mental clarity and overall body balance.
Spas are known and understood for providing external treatments to enhance the health and beauty of the skin. Sequence XO, with products as Calm; give spas and their clients the opportunity to enhance their topical treatments with internal nutrition. Relaxation is just one tablet and one treatment away when Calm is combined with popular spa treatments. Calm's adaptogenic (stress aiding) formulation is unique and unmatched to any other nutritional product in the market today. The internal/external treatment combination is what creates the harmony between the spa, spa goer and Sequence XO nutraceuticals.
About Sequence XO
Sequence XO is a member of the prestige International SPA Association and Day Spa Association. Sequence XO is unique to the spa and wellness industry with innovative delivery systems for their nutritional products such as effervescent, powders and liquid concentrates to enhance the health benefits offered by spa treatments. Sequence XO is dedicated to keeping the spa experience luxurious and unique by enhancing the results of its clients to better health, wellness and beauty from the inside out.
---
Press release service and press release distribution provided by http://www.24-7pressrelease.com# # #
Read more Press Releases from Karen Lopez:Other Press Release Headlines:
